Harvard Bioscience Inc.

NASDAQ:HBIO   3:59:50 PM EDT
3.16
-0.03 (-0.94%)
Earnings Announcements

Harvard Bioscience Says Qtrly EPS $0.06

Published: 08/04/2022 02:59 GMT
Harvard Bioscience Inc. (HBIO) - Harvard Bioscience Announces Second Quarter 2022 Financial Results.
Qtrly EPS $0.06.
Qtrly Diluted Adjusted Earnings per Share $0.05.
Qtrly Revenue $29.2 Million Versus $29.2 Million a Year Ago.
Sees FY 2022 Revenue Growth 1-to-5% and Adjusted Operating Margin of 13-to-14%.
Revenue is expected to be $28.65 Million
Adjusted EPS is expected to be $0.06

Next Quarter Revenue Guidance is expected to be $34.15 Million
Next Quarter EPS Guidance is expected to be $0.09

More details on our Analysts Page.